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Qi-Chao Xie* and Yu-Peng YangAbstract
Background: Lung cancers are leading causes of cancer death, and Rumex japonicus has been traditionally used in
folk medicine as anti-microorganic, anti-inflammatory and anti-tumor agents. This study was designed to investigate
the anti-proliferative activity of physcion 8-O-β-glucopyranoside (PG) isolated from Rumex japonicus Houtt. on A549
cell lines.
Methods: In our present study, PG was isolated and identified from the ethanol extracts of R. japonicus. MTT method
was used to evaluate the anti-proliferative activity of PG on A549 cell lines, and cell cycle distribution assay, apoptosis
assay, and western blot analysis in vitro were used to explore the possible mechanisms.
Results: From the results of our present study, cell viability was obviously inhibited by PG, in a dose- and
time-dependent manner. Our results also suggested that the anti-proliferative effect of PG was related to cell
cycle arrest at the G2/M phase through repression of cdc2 and Cyclin B1 protein expression. In addition, the results of
apoptosis assay and western blot analysis indicated that the anti-proliferative activity could be related to apoptosis via
up-regulating the expressions of Bax, caspase-3 and caspase-7, and down-regulating the expressions of Bcl-2.
Conclusions: In conclusion, the PG has significant anti-proliferative activity on A549 cell lines, and the possible
mechanism was related to cell cycle arrest at the G2/M phase, and apoptosis via the regulations of Bax, Bcl-2, and
caspase-3 and caspase-7.
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Lung cancers are the leading causes of cancer death
worldwide. Lung cancers are commonly classified as
small cell lung cancer (SCLC) and non-small cell lung
cancer (NSCLC), and NSCLC constitutes approximately
80% of the lung cancer cases [1-3]. It’s well known that
smoking is the predominant etiologic risk factor for lung
cancers, and polycyclic aromatic hydrocarbons are re-
ported as the major causative agents among cigarette
smoke components for lung cancer development [2,4].
Currently, chemotherapy is still the major therapeutic
method for lung cancers after surgery resection, and this* Correspondence: xieqctmmu@126.com
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unless otherwise stated.treatment can significantly improve the survival rate of
patients [5,6]. However, the long-term survival rate re-
mains low and the 5-years survival rate after surgery is
less than 70% [5,7]. Besides, the synthetic drugs, which
have severe side effects, are commonly the only option
for cancer chemotherapy [8,9]. Therefore, it is important
to search for new reliable therapeutic agents with low
toxicity to lung cancer treatment. Traditional Chinese
medicine (TCM) has been used for cancer treatment for
a long time either being used alone or in combination
with western medicines [10]. And natural products iso-
lated from the plants are important sources of cancer
therapies [11,12].
Rumex japonicus Houtt, a perennial herb plant be-
longing to the family Polygonaceae, is widely distributedl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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has been traditionally used in folk medicine as anti-
microorganic, purgative, anti-inflammatory and anti-tumor
agents [13-15], and R. japonicus contains a large number
of anthraquinones, oxanthrones, and flavones [13,14,16].
However, there has been no report regarding the ac-
tive anti-tumor compounds isolated from R. japonicus
and its possible mechanisms thus far. Physcion 8-O-β-
glucopyranoside (PG), one of the major bioactive com-
pounds presented in the R. japonicus, is an anthraquinones.
The aim of the present study is to investigate the anti-




Rumex japonicus Houtt was purchased from the Chuqimen
Market of Traditional Chinese Herbs and identified as the
roots of R. japonicus by the department of Traditional
Chinese Medicine of the Second Affiliated Hospital, Third
Military Medical University. A vouncher specimen of
R. japonicus (No. RJ2010-09) was deposited at the Second
Affiliated Hospital, Third Military Medical University.
Cells culture
Human lung cancer cell line A549, human Myeloid
Leukemia cell Line IL-60, human breast cancer cell
line MCF-7, colonic carcinoma cell Line HCT-8, human
cervical carcinoma cell line Hela, and human hepatoma
cell line HepG2 were purchased from American Type
Culture Collection. The cells were cultured in RPMI-
1640 medium (Gibco, CA, USA) with 10% fetal bovine
serum (Gibco, CA, USA) and antibiotics (100 U/mL peni-
cillin and 100 μg/mL streptomycin). The cell line was kept
at 37°C in 5% CO2/95% air.
Chemicals
Silica-gel (100–200, 200–300 mesh) was purchased from
Qingdao Haiyang Chemical Co., Ltd. (Qingdao, China);
methanol (MeOH) [analytical reagent grade (AR)],
Petroleum ether (AR), ethyl acetate (AR), n-butanol (AR)
were purchased from Sinopharm chemical reagent
Co., Ltd. (Shanghai, China); Sephadex LH-20 was
purchased from H&E Co., Ltd. (Beijing, China). The
RPMI 1640 media and fetal bovine serum (FBS) were
purchased from Invitrogen (Carlsbad, USA). Methyl-
thiazdyldiphenyl-tetrazolium bromide (MTT) and di-
methyl sulfoxide were purchased from Sigma (NY,
USA). Human phospho-Cdc2 (Tyr15), Cdc2, Cyclin B1,
caspase-3, caspase-7, Bax and Bcl-2 monoclonal antibody
and Annexin V/FITC kit was purchased from Beyotime
Institue of Biotechnology (Haimen, China). All other
chemicals used in this study were of analytical reagent
grade.Extraction, isolation and preparation of total extracts and
pure compounds
Dried R. japonicus (50 kg) was powdered and extracted
with 75% aqueous ethanol by reflux three times (each
extraction period lasted 3 h). The solvent was evapo-
rated under vacuum to afford crude total extract of
R. japonicus. Then the extract was suspended in water
and partitioned with petroleum ether, chloroform, ethyl
acetate, and aqua-saturated n-butanol successively. The
n-butanol fraction was subjected to repeated column
chromatography over silica gel (100–200 mesh) column
chromatography and eluted with ethyl acetate-methanol
(20:1 ~ 1:2). Then, similar fractions were combined based
on the basis of thin layer chromatography analysis (TLC),
and 7 fractions (I-VII) were obtained. By using a series
of chromatographic techniques, such as silica gel column
chromatography (200–300 mesh) and Sephadex LH-20
chromatography, the compound was isolated from frac-
tions III (140 mg) [16,17].
MTT reduction assay
Cells (1 × 104/0.2 mL) were seeded in 96-well plates and
treated on the following day with PG ranged from 5 μg/ml
to 80 μg/ml (for 24 or 48 h, respectively). After that, MTT
assay was carried out [9] and optical density (OD) was read
at 570 nm using a 96-well plate reader. Since reduction of
MTT only occurred in metabolically active cells, the level
of activity was a measure of the viability of the cells. The
inhibition rate was calculated according to the following
formula: (ODcontrol – ODtreatment)/ODcontrol × 100%. The
IC50 (inhibitor concentration at which occurs 50% inhib-
ition of proliferation) value was calculated using Bliss
method by SPSS software.
Cell cycle distribution assay
A549 Cells (5 × 105/mL) were seeded in 6-well plates.
On the following day, the cells were treated with 20, 40
and 80 μg/mL of PG for 24 h, or treated with 80 μg/mL
of PG for 12, 24, 48 h, respectively. Then, cells were
trypsinized, washed with Phosphate Buffered Saline
(PBS) and fixed in 1 mL of ice-cold 70% ethanol over-
night at 4°C. The cells were concentrated by removing
ethanol and treated with 0.01% Dnase-free RNase A for
10 min at 37°C. Cellular DNA was stained with 0.05%
propidium iodide (PI) for 20 min at 4°C in darkness.
The cell cycle distribution was detected with flow cy-
tometry (FCM) on a FACScalibur cytometer (Becton
Dickinson, US). The percentage of cells at G1, S, or G2/M
phase was documented using ModFit software (Becton
Dickinson, US).
Apoptosis assay
Two methods were used for apoptosis assays. Firstly, A549
Cells (5 × 105/mL) were seeded in 6-well plates. On the
Table 1 IC50 of the total extracts of Rumex japonicus Houtt
Cells IL-60 A549 MCF-7 HCT-8 Hela HepG2
IC50(μg/mL) 127.43 ± 3.12 44.19 ± 1.08 >150 >150 >150 146.25 ± 3.97
Cells were treated with PG for 48 h, and the MTT assay were determined to obtain the IC50.
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80 μg/mL of PG. 48 hours later, cells were trypsinized,
washed with PBS and stained using an Annexin V/FITC
kit. The cells were detected with flow cytometry (FCM) on
a FACScalibur cytometer (Becton Dickinson, US).
Secondly, the cells (1 × 104/0.2 mL) were seeded in 96-
well plates and then treated with 100 nM of Ac-DEVD-
CHO (caspase inhibitor) [18] for 3 h. The cells were
treated with PG (20, 40 and 80 μg/mL) for 48 h. Cells
survival was determined by MTT assay to evaluate
whether the anti-proliferative effect of PG was related to
apoptosis through caspase pathway that lead to apoptotic.
Western blot analysis
A549 Cells (5 × 105/mL) were seeded in 6-well plates.
On the following day, the cells were treated with 20, 40
and 80 μg/mL of PG. 48 hours later, cells were harvested
and homogenized with lysis buffer. Total cell protein
was extracted and the protein concentration was deter-
mined using BCA Protein Assay Kit (Beyotime Institue of
Biotechnology, Haimen, China). Subsequently, the total
cellular protein was separated by 12% SDS-polyacrylamide
gel electrophoresis (SDS PAGE), and transferred to PVDF
membranes (Millipore USA). Membranes were blocked
with 5% fat-free milk in TBST (10 mM Tris–HCl, 0.1 MFigure 1 Molecular structure of physcion 8-O-β-glucopyranoside.NaCl2, 0.1% Tween 20, pH 7.4), and incubated with
phospho-Cdc2 (Tyr15), Cdc2, Cyclin B1, caspase-3,
caspase-7, Bax and Bcl-2 monoclonal antibodies, respect-
ively. Protein bands were detected by incubating with
HRP-conjugated secondary antibodies (Beyotime Institue
of Biotechnology, Haimen, China) and visualized by
BeyoECL plus Kit, and then immunoblotting signals were
scanned and quantitated using a ChemiDoc XRS gel im-
aging system (Bio-Rad USA). Fold changes of protein levels
were determined by using Bio-Rad quantity one software
and compared to the protein expression of β-actin.
Statistical analysis
All results were presented as mean ± standard deviation
(SD) from at least three independent experiments.
Statistical analyses were performed using the two-tailed
Student’s t-test. Differences with the p value less than 0.05
was considered statistically significant.
Results
IC50 values of the total extract of R. japonicus on the six
human cancer cell lines
The investigation on anti-proliferative activities of the
total extract from R. japonicus was conducted, and the
results are represented in Table 1. The data demonstrated
Table 2 1H NMR (600 MHz) and 13 C NMR (150 MHz) data
of compound 1 in DMSO-d6 (δ, ppm)
Position δH (J in Hz) δc Position δH (J in Hz) δc
1 12.87 (s, −OH) 161.6 8a 114.5
2 7.17 (brs) 125.1 9a 114.4
3 147.1 10a 136.4
4 7.46 (d, 1.6 Hz) 119.3 1′ 100.9
5 7.38 (d, 2.6 Hz) 106.7 2′ 73.3
6 164.7 3′ 77.2
7 7.19 (d, 2.6 Hz) 107.5 4′ 69.8
8 3.74 (s) 161.1 5′ 76.8
9 186.4 6′ 60.8
10 181.7 3-CH3 2.39 (s) 21.3
4a 132.1 6-OCH3 3.97 (s) 56.1
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activities against IL-60 and HepG2 cell lines (IC50 were
127.43 ± 3.12, and 146.25 ± 3.97 μg/mL, respectively); fur-
thermore, no obvious anti-tumor effect was observed on
the MCF-7, HCT-8, and Hela cells (IC50 > 150 μg/mL);
however, the total extract showed a significant cyto-
toxic activity on the A549 cell line with the IC50 less
than 50 μg/mL (IC50 = 44.19 ± 1.08 μg/mL).
Analysis of the compound isolated from R. japonicas
The compound isolated from the Rumex japonicus
Houtt. was identified as physcion 8-O-β-glucopyranosideFigure 2 PG inhibits the viability of A549 cells in dose- and time-depend
as PG. Cells were seeded in 96-well plates and treated on the following day wi
viabilities were determined by MTT assay.[16,17] (Figure 1, Table 2). The spectral data of the com-
pound were as follows: Yellow needle crystals; melting
point (m.p.) 231-233°C; electrospray ionisation tandem
mass spectrometry (ESI-MS) m/z: 445.1 [M −H]−, and
it showed the molecular ion at m/z 446, which was in
accordance with the molecular formula C22H22O10.
The 1H-NMR and 13C-NMR information was shown
in Table 2.
Physcion 8-O-β-glucopyranoside inhibits the viability of
A549 cells in dose- and time-dependent manners
To evaluate the cytotoxic effect of PG on A549 cell and
get the IC50 value, the viability of cells treated with dif-
ferent concentrations (ranging from 5 to 80 μg/mL) of
PG was measured using MTT test. The result showed
that PG reduced cell survival in a dose- and time-
dependent manner (Figure 2). The IC50 of PG to A549
cell lines was 53.01 μg/mL at 24 h and 27.31 μg/mL at
48 h, respectively. Based on the results, the concentra-
tion of 20, 40 and 80 μg/mL were selected and used in
the subsequent experiment.
PG induced cell cycle arrest at G2/M phase in dose- and
time-dependent manners
Cell cycle arrest was the major reason of cell death
induced by anti-tumor drugs. Cell cycle regulation was
important for cell proliferation [19-21]. To examine
whether the anti-proliferative effect of PG was related to
cell cycle arrest, the cell cycle distribution was tested.
The results showed 20, 40 and 80 μg/mL of PG hadent manners. In the figure, Physcion 8-O-β-glucopyranoside abbreviated
th indicated concentrations of PG for 24 and 48 h, respectively, the cells
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cell cycle arrest at G2/M phase. Cell amount at G2/M
phase increased from 7.7% (medium group) to 14.6%
(20 μg/mL, PG), 20.8% (40 μg/mL PG), and even up
to 36.9% (80 μg/mL PG). Cells in the G1 or S phaseFigure 3 Cell cycle distribution of A549 cell in vitro. In the figure, 20, 40
(A and B) PG induced cell cycle arrest at G2/M phase in dose-dependent m
respectively, and then cells were harvested to determine cell cycle distribu
(C) PG induced cell cycle arrest at G2/M phase in time-dependent manners.
and then cells were harvested to determine cell cycle distribution by flow cshifted concomitantly to the changes detected in G2/M
(Figure 3). The results also showed that treatment of cells
with 80 μg/mL PG resulted in cell cycle arrest at G2/M
phase in a time-dependent manner. Cell amount at G2/M
phase increased from 8.4% (12 h) to 19.3% (24 h), evenand 80 μg/mL of PG abbreviated as PG20, PG40 and PG80, respectively.
anners. Cells were treated with 20, 40 and 80 μg/mL of PG for 24 h,
tion by flow cytometry. *p < 0.05 vs. medium; **p < 0.01 vs. medium.
Cells were treated with 80 μg/mL of PG for 12, 24, 48 h, respectively,
ytometry.
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effect of PG was related to cell cycle arrest at the G2/M
phase.
Effect of PG on the expression of G2/M cell cycle
regulatory proteins
Our data showed that PG-mediated anti-proliferative
effects were accompanied by cell cycle arrest at G2/M
phase. Cell cycle progression through G2/M is regu-
lated principally by the sequential activation of the
Cyclin B/Cdc2. To explore the mechanism by which
PG induced the cell cycle arrest at the G2/M phase in
A549 cells, we used western blot assay to determine if
PG modulate the expression of G2/M cell cycle regu-
latory molecules. The results demonstrated that treat-
ment of A549 cells with 20, 40, 80 μg/mL of PG for
48 h resulted in a 0.6, 0.34, 0.08 fold decrease in expres-
sion of Cyclin B1 and a 0.78, 0.49, 0.33 fold decrease
of phospho-Cdc2 (Tyr15) compared to control group
(Figure 4). On the other hand, total levels of Cdc2
remained largely unchanged after treatment (Figure 4).
These data suggested decreased cyclin B1 and cdc2 pro-
tein expressions contributed to G2/M arrest induced by
PG in A549 cells.Figure 4 Effect of PG on the cyclin proteins of Cdc2 and cyclin B1. In
PG80, respectively. Physcion 8-O-β-glucopyranoside abbreviated as PG. A549
the cells were collected for western blot assay in vitro.PG induced A549 cell apoptosis
In order to make sure whether the anti-proliferative ef-
fect of PG on A549 cell was due to apoptosis, the flow
cytometry analysis was used. Our results revealed PG could
significantly increase apoptosis of the cells compared to
medium. 20, 40 and 80 μg/mL of PG produced a 26.9%,
53.7% and 70.72% of propidium iodide (+)/annexin V (+)
cells (necrosis/late apoptosis), respectively, However, the
medium group only produced 4.86% of cells (necrosis/late
apoptosis) (Figure 5A). To further confirm 20, 40 and
80 μg/mL of PG indeed increased apoptosis, Ac-DEVD-
CHO, a caspase inhibitor [22], was used. The results
further demonstrated PG in combination with Ac-DEVD-
CHO could partly reverse the anti-proliferative effect com-
pared to PG-alone treatment group (Figure 5B).
PG induce apoptosis via Caspase pathway
It is well known that most cell apoptosis-inducing fac-
tors eventually cause cell apoptosis through the caspase-
mediated signal transduction pathway. Caspase 3 and
caspase 7 is the executioner caspases in the caspase cas-
cade that lead to apoptotic [22].
Bax is a well-known pro-apoptotic protein and Bcl-2
is an anti-apoptotic protein, the ratio of Bcl-2/Bax has athe figure, 20, 40 and 80 μg/mL of PG abbreviated as PG20, PG40 and
cells were treated with PG (20, 40 and 80 μg/mL) for 48 h, and then
Figure 5 Apoptosis of A549 cell in vitro. In the figures, Ac-DEVD-CHO abbreviated as Ac, 20, 40 and 80 μg/mL of PG abbreviated as PG20,
PG40 and PG80, respectively. (A) The cell Apoptosis was determined by flow cytometry. The cells were treated with 20, 40 and 80 μg/mL of
PG. 48 hours, and then cells were trypsinized, washed with PBS and stained using an Annexin V/FITC kit. The cell apoptosis was detected with
flow cytometry. Fluorescence intensity for annexin V/FITC is plotted on the x-axis, and PI is plotted on the y-axis. (B) The cells were treated
with or without Ac-DEVD-CHO for 3 h, then incubation with 20, 40 and 80 μg/mL of PG for 48 h, then MTT assay was carried out. **p < 0.01 vs. medium;
# #p< 0.01 vs. PG.
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whether the apoptosis was regulated by caspase-3,
caspase-7, Bax and Bcl-2 proteins, we measured the ex-
pression of caspase-3, caspase-7, Bax and Bcl-2 proteins
in A549 cells treated with 20, 40 and 80 μg/mL of PG
using Western blot analysis. Our data showed that after
20, 40 and 80 μg/mL of PG treatment, the cleaved
Caspase-3 were increased 2.1, 5.8, 7.2 fold, the cleaved
caspase-7 were increased 2.8, 7.0, 9.6 fold, and the pro-
tein expression of Bcl-2 level was decreased, but the Bax
expression level was increased, when compared to the
medium group (Figure 6). Therefore, the ratio of Bcl-2/
Bax was significantly increased after PG treatment, when
compared with the medium. All results showed that cell
apoptosis is also a major reason of PG anti-proliferative
effect, and the Caspase-3, Caspase-7, Bcl-2 and Bax are
involved.
Discussion
Nowadays, cancer is recognized as a chronic and refrac-
tory disease that markedly affects patient quality of life.
Furthermore, cancer is an important cause of substantialFigure 6 The protein expression of caspase-3, Bax, Bcl-2 and caspase
of PG abbreviated as PG20, PG40 and PG80, respectively. A549 cells were tr
collected for western blot assay in vitro. *p < 0.05 vs. control; **p < 0.01 vs. cmedical care expenditures. Currently, approximately 40%
cancer patients with stage III or IV NSCLC currently can
not be resected, and chemotherapy is the major treatment
in such cancer patients [5]. However, the prolonged use of
these drugs can induce the unbearable side-effects. There-
fore, how to find the novel treatment strategies against
NSCLC cancer with less adverse side-effects became a
serious and urgent problem.
As a part of our continuing study regarding investigat-
ing the anti-cancer agents derived from TCMs, this
study was designed to examine the effect of PG on cell
proliferation, cell cycle, and apoptosis in A549 cells. To
the best of our knowledge, this is the first report regard-
ing anti-tumor activity of PG. Interestingly, the present
study showed that PG significantly inhibited cell prolifer-
ation in dose-dependent manners and this inhibitory
effect resulted from cell cycle arrest at G2/M phase.
Additionally, we also found that exposure of A549 cells
to PG resulted in an obvious increase in apoptosis, sug-
gesting that apoptosis and cell cycle arrest contribute to
growth inhibition in PG-treated A549 cells. G2 to M
phase progression is regulated by a number of proteins-7 by western blot assay in vitro. In the figure, 20, 40 and 80 μg/mL
eated with 20, 40 and 80 μg/mL of PG for 48 h, then the cells were
ontrol.
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the Cdc2/Cyclin B1 complex is required for transition
from G2 to M phase of the cell cycle [25]. To elucidate
the mechanism by which PG-induced cell cycle arrest at
G2/M phase, we determined the expressions of phospho-
Cdc2 (Tyr15) and Cyclin B1 in A549 cells treated with
PG. The results of our present study showed that PG
markedly down-regulated the expressions of Cyclin B1
and the phosphorylation of Cdc2 at Tyr15, suggesting
that repression of cdc2 and Cyclin B1 is likely to be in-
volved in PG-induced G2/M arrest. Collectively, the re-
sults of our study indicated that PG treatment could
potentially inhibit the proliferation of A549 cells by cell
cycle arrest at G2/M phase.
Apoptosis is one of the major mechanisms of cell
death in response to cancer therapies, and caspases
proteins play the key roles in the execution phase of
apoptosis. Caspase 3 and caspase 7 are the executioner
caspases in the caspase cascade that lead to apoptosis.
Caspase-3 is a caspase protein that interacts with
caspase-8 and caspase-9, encoded by the CASP3 gene
Caspase-3 has been activated in the apoptotic cell both
by extrinsic (death ligand) and intrinsic (mitochondrial)
pathways. The activated Caspase-3 induces Caspase-8
activation, then actives Bax. Bax activates Cyt c, and in-
duces apoptosis. Our results showed that Caspase-3,
caspase-7 and Bax expressions were up-regulated by
treatment with PG, whereas the protein expression level
of Bcl-2 was down-regulated. These findings above dem-
onstrate the mechanism by which PG exert their growth
inhibitory effect, is related to induce A549 cells apop-
tosis through inducing caspases pathway and cell cycle
arrest at G2/M phase.
Conclusions
In conclusion, A549 cells viability was significantly inhib-
ited by PG in vitro, in a dose- and time-dependent man-
ner, and the possible mechanism may be related to cell
cycle arrest at the G2/M phase, and apoptosis might be via
the regulations of Bax, Bcl-2, Caspase-3 and Caspase-7.
Consequently, the present results indicated that the PG is
worthy for further exploration for lung cancer treatment,
and more laboratory investigations are necessary to eluci-
date the mechanism of actions.
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